Dr. Si M. Pham is currently the Chair of Cardiothoracic Surgery at Mayo Clinic in Jacksonville Florida.
Dr. Pham is certified by the American Board of Thoracic Surgery, the American Board of Surgery, and holds a subspecialty certification in Surgical Critical Care from the American Board of Surgery. Dr. Pham received his medical degree from the University of Pittsburgh, School of Medicine, and completed residency in general, cardiac surgery at the University of Pittsburgh Medical Center. After his training, he joined the surgical faculty at the University of Pittsburgh as an Assistant Professor in 1992 and became the director of the Adult Heart Transplant and ECMO Programs at the University of Pittsburgh Medical Center for 6 years, and director of thoracic transplant research laboratory at the same institution. In 1998, Dr. Pham was recruited to Miami to be the Director of Heart/Lung Transplant and Artificial Heart Programs at University of Miami/Jackson Memorial Hospital to expand and rebuild the Heart/Lung Transplant Programs. Under the leadership of Dr. Pham, the heart transplant program at the University of Miami/Jackson Memorial Hospital was recognized by HealthGrades, a leading provider of comprehensive information about physicians and hospitals, with the Heart Transplant Excellence Award in 2011 for having the best patient survival.  In 2013, Dr. Pham was recruited to the University of Maryland School of Medicine to be a Professor of Surgery and the Director of Heart and Lung Transplantation, Circulatory Assist Device and ECMO Programs at University of Maryland Medical Center. Under his leadership the Adult ECMO program has grown from 50 a year to 180 in 2016. The lung transplant volume has increased from 24 in 2013 to 44 in 2015. The Heart and Lung Program at the University of Maryland became the busiest program in Mid-Atlantic region in 2016. In addition to being a staff the University of Maryland, Dr. Pham also has staff privilege and operated at the Johns Hopkins Hospital in Baltimore. n July 2017, Dr. Pham joined Mayo Clinic Florida as Chair of the Department of Cardiothoracic Surgery to build a program that provide state-of-the art care for patients with heart and lung diseases that requires cardiac and thoracic surgeries, including transplants, ventricular assist devices and ECMO. Dr. Pham has published 170 scientific peer-reviewed papers in leading medical journals. He has received grants from the national institute of health (NIH), the American Heart Association, the American Lung Association, and the Transplant Foundation for his research. Dr. Pham has made several seminal contributions to the field of heart/lung transplantation. His team was the first to use tacrolimus (Prograf) to prevent rejection in heart/lung transplant recipients. Dr. Pham’s team also pioneered in the use of donor bone marrow to prevent rejections in heart and lung recipients.  As a tireless promoter of organ transplantation Dr. Pham had served in the Board of The Transplant Foundation, Inc., and had participated in many of educational activities to promote organ donations and organ transplantation. As a tribute to his achievements, Dr. Pham was granted the Award for Excellence in Medical Research by the Vietnamese American Medical Research Foundation in 2005, and the Health Care Heroes Award by the Greater Miami Chamber of Commerce in 2007. In addition, The Mayor and the Board of County Commissioners of The Miami-Dade County had declared April 19, 2013 as Dr. Si Pham’s Day.

Dr. Langer has been a member of Noveome’s Board of Directors for over 10 years. He is one of only 12 Institute Professors (MIT’s highest honor). He has written 1,500 articles and has approximately 1350 issued and pending patents. His patents have been licensed or sublicensed to over 400 companies. Dr. Langer has received over 220 major awards including the United States National Medal of Science and the United States National Medal of Technology and Innovation (he is one of 4 living individuals to have received both these honors), the Charles Stark Draper Prize (often called the Engineering Nobel Prize), Queen Elizabeth Prize for Engineering and Priestley Medal (highest award of the American Chemical Society.) He holds 34 honorary doctorates and has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.

Dr. Shindler joined the University of Pennsylvania Faculty in 2004, where he has risen to the position of tenured Associate Professor of Ophthalmology and Neurology and serves as a Faculty member of the Neuroscience Graduate Group and the Institute for Immunology.  The main focus of Ken’s research is to understand mechanisms of neuronal damage during optic neuritis, an inflammatory disease of the optic nerve that occurs in the central nervous system demyelinating disease multiple sclerosis. His studies include identification of novel neuroprotective therapies to reduce neuronal loss in multiple sclerosis.  Ken is also an active investigator in clinical trials in neuro-ophthalmology and retinal degenerative diseases.  Clinically, he sees patients with neuro-ophthalmologic problems at the Scheie Eye Institute and directs the neuro-ophthalmology clinic at the Philadelphia Veteran’s Administration Medical Center.  Ken has authored or co-authored more than 60 peer-reviewed papers, including over 30 papers in the field of experimental optic neuritis/optic nerve injury and central nervous system demyelinating disease, a major focus of his laboratory.  Ken has served on the Annual Meeting Program Committee for the Association for Research in Vision and Ophthalmology, the Research Committee of the North American Neuro-Ophthalmology Society, and the Annual Meeting Program Committee for the American Academy of Ophthalmology, and is an active member of the Society for Neuroscience, Society of Heed Fellows, and Research to Prevent Blindness.  Ken was honored with the North American Neuro-Ophthalmology Society Young Investigator Award in 2008, the American Academy of Ophthalmology Achievement Award in 2014, and the Research to Prevent Blindness Physician-Scientist Award in 2015.

Dr. Sahel is currently the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear Foundation Chair of Ophthalmology. Dr. Sahel founded and still leads the Institut de la Vision in Paris, a research center associated with the one of the oldest eye hospitals in the world Quinze-Vingts National Eye Hospital in Paris, founded in 1260, and is Professor of Ophthalmology at the Sorbonne Université medical school in Paris. He is a pioneer in the field of artificial retina and eye regenerative therapies and is a member of the French and German Academies of Sciences.

Dr. Hamrah is a clinician/scientist ophthalmologist and immunologist who has focused his research activities on antigen presenting cells. He has authored over 50 peer-reviewed articles, over 30 reviews and book chapters, and has given more than 60 lectures and presentations worldwide. He has been the recipient of numerous awards, including the Claes Dohlman Society Award, the American Society of Cataract and Refractive Surgery Excellence in Research Scholarship Award, and the Association of University Professors of Ophthalmology/Research to Prevent Blindness Resident and Fellow Research Award, the Achievement Award from the American Academy of Ophthalmology and was most recently awarded Silver Fellow at the Association for Research in Vision and Ophthalmology. Dr. Hamrah currently serves as the Section Editor for Clinical Science and Clinical Practice of the journal The Ocular Surface, Cornea Section Editor of the journal Eye, Assistant Editor of the journal Ocular Immunology and Inflammation, and Ophthalmology Associate Editor for BMC Ophthalmology. He serves on numerous additional editorial boards and is a peer reviewer for over 45 ophthalmology, immunology and transplantation journals. He is an Instructor at the American Academy of Ophthalmology and recently served as Chair of the ARVO Members-in-Training Committee.

Dr. Hanson is an internationally recognized expert in the development and use of intranasally-administered therapeutics to target the brain for treatment of disease associated with neurodegenerative disorders. As a Senior Research Investigator and Senior Director of Neuroscience Research at HealthPartners Institute and Co-Director of Research at the HealthPartners Center for Memory and Aging, she directly manages the HealthPartners Institute laboratory facilities and staff trained in conducting small and large animal studies. Dr. Hanson’s career has been devoted to the development of novel therapeutic delivery methods for the treatment and prevention of neurologic diseases, especially those that impact older adults such as Alzheimer’s, Parkinson’s disease, and stroke. She has numerous publications and patents in the field of intranasal delivery with a wide range of experience from leading numerous pre-clinical to clinical studies to experience with infrastructure projects and observational studies.